NCT06874517 Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot
| NCT ID | NCT06874517 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beylikduzu State Hospital |
| Condition | Hallux Valgus |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2025-04-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-03-10 with a primary completion date of 2025-04-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study. Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes. The ratio of the second toe phalanx length to the first toe phalanx length will be calculated and recorded. The relationship between the hallux valgus angle, toe lengths, and their ratios will be analyzed using statistical methods.
Eligibility Criteria
Inclusion Criteria: * Age between 60-80 years * Presence of foot radiographs suitable for measurement * No history of prior foot surgery Exclusion Criteria: * History of foot trauma or fractures * Previous foot or toe surgery * Presence of congenital foot deformities * Neurological or rheumatologic conditions affecting foot structure * Severe osteoarthritis or other degenerative foot diseases visible on radiographs
Frequently Asked Questions
Who can join the NCT06874517 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying Hallux Valgus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06874517 currently recruiting?
Yes, NCT06874517 is actively recruiting participants. Visit ClinicalTrials.gov or contact Beylikduzu State Hospital to inquire about joining.
Where is the NCT06874517 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06874517 clinical trial?
NCT06874517 is sponsored by Beylikduzu State Hospital. The trial plans to enroll 150 participants.